FDA approval is ______ if the increase in costs to patients (including the increase in deaths)is less than the increase in benefits due to more rapid approval

Question

Quizplus · Accepted Answer

FDA approval is considered too stringent if the increase in costs to patients, including the increase in deaths, is less than the increase in benefits due to more rapid approval. This implies that the regulatory process may be overly cautious, delaying access to potentially beneficial treatments.

FDA Approval Is ______ If the Increase in Costs to Patients